use of vmp daratumumab in myeloma
Published 6 years ago • 36 plays • Length 3:19Download video MP4
Download video MP3
Similar videos
-
3:54
vmp daratumumab for high-risk multiple myeloma
-
3:39
potential of vrd daratumumab in myeloma
-
1:03
promising findings for daratumumab plus vrd in multiple myeloma
-
1:07
fda approval of frontline daratumumab plus vmp in multiple myeloma
-
1:45
dr. fakhri on daratumumab plus vmp in multiple myeloma
-
3:15
daratumumab for the treatment of patients with multiple myeloma
-
1:47
practical management of iv daratumumab in mm
-
3:08
clinical impact of subq daratumumab for multiple myeloma
-
0:44
key findings from alcyone trial in myeloma
-
2:07
myeloma: impact of the alcyone trial
-
1:58
treatment options for patients with multiple myeloma who are resistant to daratumumab
-
12:21
elotuzumab and daratumumab in multiple myeloma
-
1:16
rationale for adding daratumumab to rvd in multiple myeloma
-
3:38
myeloma: the alcyone trial
-
2:17
opinion: eu approval of daratumumab plus vmp for frontline transplant-ineligible multiple myeloma
-
1:23
dr. landgren on using daratumumab for patients with multiple myeloma
-
3:13
dr. laubach on daratumumab as a potential treatment option for multiple myeloma
-
4:03
maia and alcyone: follow-up of daratumumab in multiple myeloma
-
3:05
sc daratumumab plus standard-of-care regimens in myeloma